• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL OPTICS INTRALASE FS2; FEMTOSECOND LASER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL OPTICS INTRALASE FS2; FEMTOSECOND LASER Back to Search Results
Model Number 20003D
Device Problem Device Displays Incorrect Message (2591)
Patient Problems Blurred Vision (2137); Visual Impairment (2138); No Code Available (3191)
Event Date 03/01/2015
Event Type  Injury  
Event Description
The surgery center reported that a laser vision correction patient that was treated for hyperopic astigmatism and under corrected for near vision on the left eye was presented with macrostriae, a dislodged flap and epithelial ingrowth in the exposed stromal bed on the left eye at 1 day post op.The patient¿s chief complaint at the one day post op visit was blurry and loss of best corrected visual acuity.In addition, the patient stated the left eye felt the same as her right eye that was treated years ago.Best correct visual acuity for left eye was distance 20/200, pre-op 20/20.Although, the surgery reported at one day post op, the event was lasting and disabling, significantly interfering with daily activities, at a later time on the same date of evaluation, the event was not lasting and disabling, significantly interfering with the daily activities.A flap lift/rinse, debridement and repositioning was performed and topical steroid dosage was increased.In addition, the patient at the one day post op visit requested a monovision treatment.The monovision was not requested by patient initially.The monovision enhancement treatment will be scheduled after 3 months or more.The surgery center indicated the laser system had in recent weeks 3 errors for (b)(4) displaced and 3 aborted patient interface (pi) docks then rebooted laser system to repeat the docking the pi, hence, the account was able to complete treatments.A field service specialist visited the site.
 
Manufacturer Narrative
(b)(4).The laser system was examined and tested at the customer location by an amo field service specialist (fss) for the report of the (b)(4) out of position error.The fss performed a field service checklist.The fss performed all calibrations and measured the gel multiple times as part of the field service checklist.The system was verified for all modes of operations.The system met amo specifications.All pertinent information available to abbott medical optics has been submitted.Placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTRALASE FS2
Type of Device
FEMTOSECOND LASER
Manufacturer (Section D)
ABBOTT MEDICAL OPTICS
santa ana CA
Manufacturer (Section G)
ABBOTT MEDICAL OPTICS INC.
510 cottonwood drive
milpitas CA 95035
Manufacturer Contact
valerie sedzicki
1700 east st. andrew place
santa ana, CA 92705
7142478567
MDR Report Key4633658
MDR Text Key20785763
Report Number3006695864-2015-00094
Device Sequence Number1
Product Code HNO
Combination Product (y/n)N
PMA/PMN Number
K060372
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 03/01/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/25/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model Number20003D
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/01/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/31/2007
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
WAVELIGHT SERIAL NO.(B)(4)
Patient Outcome(s) Required Intervention;
Patient Age44 YR
-
-